vs
Smurfit Westrock（SW）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
Smurfit Westrock的季度营收约是TENET HEALTHCARE CORP的1.4倍（$7.7B vs $5.5B），TENET HEALTHCARE CORP净利率更高（11.7% vs 0.8%，领先10.8%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 0.7%），过去两年Smurfit Westrock的营收复合增速更高（61.2% vs 1.5%）
Smurfit Westrock plc是总部位于爱尔兰都柏林的企业，核心业务为生产瓦楞包装及各类纸制包装产品，公司股票同时在纽约证券交易所和伦敦证券交易所挂牌上市。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
SW vs THC — 直观对比
营收规模更大
SW
是对方的1.4倍
$5.5B
营收增速更快
THC
高出8.2%
0.7%
净利率更高
THC
高出10.8%
0.8%
两年增速更快
SW
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.7B | $5.5B |
| 净利润 | $63.0M | $644.0M |
| 毛利率 | 16.4% | — |
| 营业利润率 | 3.3% | 15.4% |
| 净利率 | 0.8% | 11.7% |
| 营收同比 | 0.7% | 9.0% |
| 净利润同比 | 0.0% | 12.6% |
| 每股收益（稀释后） | $0.12 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SWTHC
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.6B | $5.5B | ||
| Q3 25 | $8.0B | $5.3B | ||
| Q2 25 | $7.9B | $5.3B | ||
| Q1 25 | $7.7B | $5.2B | ||
| Q4 24 | $7.5B | $5.1B | ||
| Q3 24 | $7.7B | $5.1B | ||
| Q2 24 | $3.0B | $5.1B |
净利润SWTHC
| Q1 26 | $63.0M | — | ||
| Q4 25 | $97.0M | $644.0M | ||
| Q3 25 | $246.0M | $579.0M | ||
| Q2 25 | $-28.0M | $522.0M | ||
| Q1 25 | $384.0M | $622.0M | ||
| Q4 24 | $146.0M | $572.0M | ||
| Q3 24 | $-150.0M | $681.0M | ||
| Q2 24 | $132.0M | $477.0M |
毛利率SWTHC
| Q1 26 | 16.4% | — | ||
| Q4 25 | 18.2% | — | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 20.6% | — | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 23.3% | — |
营业利润率SWTHC
| Q1 26 | 3.3% | — | ||
| Q4 25 | 5.1% | 15.4% | ||
| Q3 25 | 6.6% | 16.8% | ||
| Q2 25 | 3.2% | 15.6% | ||
| Q1 25 | 7.2% | 18.1% | ||
| Q4 24 | 5.3% | 16.2% | ||
| Q3 24 | 0.7% | 21.3% | ||
| Q2 24 | 8.2% | 14.9% |
净利率SWTHC
| Q1 26 | 0.8% | — | ||
| Q4 25 | 1.3% | 11.7% | ||
| Q3 25 | 3.1% | 10.9% | ||
| Q2 25 | -0.4% | 9.9% | ||
| Q1 25 | 5.0% | 11.9% | ||
| Q4 24 | 1.9% | 11.3% | ||
| Q3 24 | -2.0% | 13.3% | ||
| Q2 24 | 4.4% | 9.3% |
每股收益（稀释后）SWTHC
| Q1 26 | $0.12 | — | ||
| Q4 25 | $0.18 | $4.22 | ||
| Q3 25 | $0.47 | $3.86 | ||
| Q2 25 | $-0.05 | $3.14 | ||
| Q1 25 | $0.73 | $4.27 | ||
| Q4 24 | $-0.12 | $3.79 | ||
| Q3 24 | $-0.30 | $4.89 | ||
| Q2 24 | $0.51 | $2.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.9B |
| 总债务越低越好 | $980.0M | $13.1B |
| 股东权益账面价值 | $18.1B | $4.2B |
| 总资产 | $45.2B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.05× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资SWTHC
| Q1 26 | — | — | ||
| Q4 25 | $892.0M | $2.9B | ||
| Q3 25 | $851.0M | $3.0B | ||
| Q2 25 | $778.0M | $2.6B | ||
| Q1 25 | $797.0M | $3.0B | ||
| Q4 24 | $855.0M | $3.0B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | $26.8K | $2.9B |
总债务SWTHC
| Q1 26 | $980.0M | — | ||
| Q4 25 | $13.4B | $13.1B | ||
| Q3 25 | $13.3B | $13.1B | ||
| Q2 25 | $13.3B | $13.1B | ||
| Q1 25 | $12.9B | $13.1B | ||
| Q4 24 | $12.5B | $13.1B | ||
| Q3 24 | $13.2B | $12.8B | ||
| Q2 24 | — | $12.8B |
股东权益SWTHC
| Q1 26 | $18.1B | — | ||
| Q4 25 | $18.3B | $4.2B | ||
| Q3 25 | $18.4B | $4.0B | ||
| Q2 25 | $18.3B | $3.7B | ||
| Q1 25 | $17.9B | $4.2B | ||
| Q4 24 | $17.4B | $4.2B | ||
| Q3 24 | $18.0B | $3.8B | ||
| Q2 24 | $14.5K | $3.5B |
总资产SWTHC
| Q1 26 | $45.2B | — | ||
| Q4 25 | $45.2B | $29.7B | ||
| Q3 25 | $45.6B | $29.4B | ||
| Q2 25 | $45.7B | $28.7B | ||
| Q1 25 | $44.6B | $29.2B | ||
| Q4 24 | $43.8B | $28.9B | ||
| Q3 24 | $45.0B | $29.4B | ||
| Q2 24 | $26.8K | $29.3B |
负债/权益比SWTHC
| Q1 26 | 0.05× | — | ||
| Q4 25 | 0.73× | 3.10× | ||
| Q3 25 | 0.72× | 3.26× | ||
| Q2 25 | 0.73× | 3.49× | ||
| Q1 25 | 0.72× | 3.13× | ||
| Q4 24 | 0.72× | 3.14× | ||
| Q3 24 | 0.73× | 3.33× | ||
| Q2 24 | — | 3.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $204.0M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | — | $367.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | 3.24× | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势，按日历期对齐
经营现金流SWTHC
| Q1 26 | $204.0M | — | ||
| Q4 25 | $1.2B | $731.0M | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $829.0M | $936.0M | ||
| Q1 25 | $235.0M | $815.0M | ||
| Q4 24 | $781.0M | $-331.0M | ||
| Q3 24 | $320.0M | $1.0B | ||
| Q2 24 | $340.0M | $747.0M |
自由现金流SWTHC
| Q1 26 | — | — | ||
| Q4 25 | $612.0M | $367.0M | ||
| Q3 25 | $523.0M | $778.0M | ||
| Q2 25 | $307.0M | $743.0M | ||
| Q1 25 | $-242.0M | $642.0M | ||
| Q4 24 | $212.0M | $-661.0M | ||
| Q3 24 | $-192.0M | $829.0M | ||
| Q2 24 | $163.0M | $602.0M |
自由现金流率SWTHC
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 6.6% | ||
| Q3 25 | 6.5% | 14.7% | ||
| Q2 25 | 3.9% | 14.1% | ||
| Q1 25 | -3.2% | 12.3% | ||
| Q4 24 | 2.8% | -13.0% | ||
| Q3 24 | -2.5% | 16.2% | ||
| Q2 24 | 5.5% | 11.8% |
资本支出强度SWTHC
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 6.6% | ||
| Q3 25 | 7.6% | 5.3% | ||
| Q2 25 | 6.6% | 3.7% | ||
| Q1 25 | 6.2% | 3.3% | ||
| Q4 24 | 7.5% | 6.5% | ||
| Q3 24 | 6.7% | 4.2% | ||
| Q2 24 | 6.0% | 2.8% |
现金转化率SWTHC
| Q1 26 | 3.24× | — | ||
| Q4 25 | 12.32× | 1.14× | ||
| Q3 25 | 4.61× | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | 0.61× | 1.31× | ||
| Q4 24 | 5.35× | -0.58× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | 2.58× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SW
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
